The current review highlights the roles of the IL-1/IL-1R1/IL-1Ra pathway and HMGB1/TLR4 pathway as crucial mechanisms underlying epileptogenesis and sustaining epilepsy, making them potential therapeutic targets. This evidence concerns the gene HMGB1 and epilepsy.